226 related articles for article (PubMed ID: 21755739)
1. Radiation therapy in treatment of fibrodysplasia ossificans progressiva: a case report and review of the literature.
Soldić Z; Murgić J; Radić J; Dabelić N; Jazvić M; Brozić JM; Kusić Z
Coll Antropol; 2011 Jun; 35(2):611-4. PubMed ID: 21755739
[TBL] [Abstract][Full Text] [Related]
2. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.
Kitterman JA; Kantanie S; Rocke DM; Kaplan FS
Pediatrics; 2005 Nov; 116(5):e654-61. PubMed ID: 16230464
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy in Fibrodysplasia Ossificans Progressiva: A Case Report and Systematic Review of the Literature.
Botman E; Netelenbos JC; Rustemeyer T; Schoonmade LJ; Nieuwenhuijzen JA; Teunissen BP; Visser M; Raijmakers P; Lammertsma AA; Dahele M; Eekhoff M
Front Endocrinol (Lausanne); 2020; 11():6. PubMed ID: 32117050
[TBL] [Abstract][Full Text] [Related]
4. Lumbar puncture and surgical intervention in a child with undiagnosed fibrodysplasia ossificans progressiva.
Zaghloul KA; Heuer GG; Guttenberg MD; Shore EM; Kaplan FS; Storm PB
J Neurosurg Pediatr; 2008 Jan; 1(1):91-4. PubMed ID: 18352811
[TBL] [Abstract][Full Text] [Related]
5. Optimal treatment of fibrodysplasia ossificans progressiva with surgical excision of heterotopic bone, indomethacin, and irradiation.
Benetos IS; Mavrogenis AF; Themistocleous GS; Kanellopoulos AD; Papagelopoulos PJ; Soucacos PN
J Surg Orthop Adv; 2006; 15(2):99-104. PubMed ID: 16919202
[TBL] [Abstract][Full Text] [Related]
6. Mast cell involvement in fibrodysplasia ossificans progressiva.
Gannon FH; Glaser D; Caron R; Thompson LD; Shore EM; Kaplan FS
Hum Pathol; 2001 Aug; 32(8):842-8. PubMed ID: 11521229
[TBL] [Abstract][Full Text] [Related]
7. Neurosurgical management of symptomatic thoracic spinal ossification in a patient with fibrodysplasia ossificans progressiva.
Grobelny BT; Rubin D; Fleischut P; Rubens E; Mack PF; Fink M; Placantonakis DG; Elowitz EH
J Neurosurg Spine; 2012 Mar; 16(3):285-8. PubMed ID: 22176432
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
[TBL] [Abstract][Full Text] [Related]
9. An unusual case of adult onset progressive heterotopic ossification suggesting a variant form of fibrodysplasia ossificans progressiva.
Jayasundara JA; Punchihewa GL; de Alwis DS
Singapore Med J; 2012 Apr; 53(4):e83-6. PubMed ID: 22511070
[TBL] [Abstract][Full Text] [Related]
10. Pseudomalignant heterotopic ossification.
Kaplan FS; Gannon FH; Hahn GV; Wollner N; Prauner R
Clin Orthop Relat Res; 1998 Jan; (346):134-40. PubMed ID: 9577421
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.
Shafritz AB; Shore EM; Gannon FH; Zasloff MA; Taub R; Muenke M; Kaplan FS
N Engl J Med; 1996 Aug; 335(8):555-61. PubMed ID: 8678932
[TBL] [Abstract][Full Text] [Related]
12. Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva.
Ahn J; Feldman G; Terry L; Shore EM; Kaplan FS
Clin Orthop Relat Res; 2003 Jan; (406):205-13. PubMed ID: 12579020
[TBL] [Abstract][Full Text] [Related]
13. Clinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva.
Wentworth KL; Bigay K; Chan TV; Ho JP; Morales BM; Connor J; Brooks E; Shahriar Salamat M; Sanchez HC; Wool G; Pignolo RJ; Kaplan FS; Hsiao EC
Bone; 2018 Apr; 109():104-110. PubMed ID: 29033382
[TBL] [Abstract][Full Text] [Related]
14. Fibrodysplasia ossificans progressiva (FOP).
Paim LB; Liphaus Bde L; Almeida da Silva CA
Indian Pediatr; 2003 Aug; 40(8):786-8. PubMed ID: 12951384
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia ossificans progressiva.
Brantus JF; Meunier PJ
Clin Orthop Relat Res; 1998 Jan; (346):117-20. PubMed ID: 9577418
[TBL] [Abstract][Full Text] [Related]
16. Fibrodysplasia ossificans progressiva: diagnosis and surgical management.
Trigui M; Ayadi K; Zribi M; Triki Z; Keskes H
Acta Orthop Belg; 2011 Apr; 77(2):139-44. PubMed ID: 21667723
[TBL] [Abstract][Full Text] [Related]
17. Wrist arthrodesis following ulnar bar excision in Fibrodysplasia ossificans progressiva.
Corfield L; Hampton R; McCullough CJ
J Hand Surg Br; 2000 Apr; 25(2):223-4. PubMed ID: 11062587
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the noggin (NOG) and of the activin A type I receptor (ACVR1) genes in a series of twenty-seven French fibrodysplasia ossificans progressiva (FOP) patients.
Lucotte G; Houzet A; Hubans C; Lagarde JP; Lenoir G
Genet Couns; 2009; 20(1):53-62. PubMed ID: 19400542
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen B27 allele is not correlated with fibrodysplasia ossificans progressiva.
Calvert GT; Shore EM
Clin Orthop Relat Res; 1998 Jan; (346):66-70. PubMed ID: 9577412
[TBL] [Abstract][Full Text] [Related]
20. Fibrodysplasia ossificans progressiva.
Blaszczyk M; Majewski S; Brzezinska-Wcislo L; Jablonska S
Eur J Dermatol; 2003; 13(3):234-7. PubMed ID: 12804980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
